Company Summary - Immunodiagnostic Systems Holdings PLC (LSE:IDH)
672.50p
2.50p
(-0.37%)
FTSE AIM UK 50 Health Care Equipment & ServicesMarket cap: £186.847m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Manufacturing and distributing medical diagnostic products
| Financials - Interim (30/11/2009) | ||
|---|---|---|
| Turnover | £m | 16.9 |
| Pre-tax Profit | £m | 4.58 |
| EPS | p | 12.15 |
| DPS | p | 1.65 |
| Director | Board Role |
|---|---|
| David Evans | Chairman |
| Dr. Roger Duggan | Chief Executive |
| Paul Hailes | Finance Director & Company Sec |
| Tony Wilks | Sales/Mkt Director |
Products Brands & Subsidiaries
Products & Brands
There are no products for this company.
Subsidiaries
IDS GmbH; Suomen Bioanalytiikka Oy (SBA Sciences Ltd); Immunodiagnostic Systems Ltd; Immunodiagnostic Systems SA...
Broker Sentiment (4 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Share options | 09/02/2010 |
| Exercise of Share Options and Tot... | 01/02/2010 |
| Five year distribution agreement | 04/01/2010 |